Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$7K 894
2022
Q2
$7K Sell
100
-296
-75% -$27K ﹤0.01% 681
2022
Q1
$51K Hold
396
﹤0.01% 536
2021
Q4
$53K Buy
396
+136
+52% +$19.5K ﹤0.01% 554
2021
Q3
$36K Buy
+260
New +$32.8K ﹤0.01% 566
2016
Q4
Sell
-452
Closed -$10K 1113
2016
Q3
$10K Hold
452
﹤0.01% 848
2016
Q2
$9K Buy
452
+272
+151% +$4.63K ﹤0.01% 873
2016
Q1
$3K Buy
+180
New +$3.01K ﹤0.01% 1040
2015
Q4
Sell
-240
Closed -$5K 1090
2015
Q3
$5K Sell
240
-320
-57% -$7.14K ﹤0.01% 958
2015
Q2
$11K Buy
+560
New +$9.84K ﹤0.01% 853

Other funds holding DXCM

MUFG Americas's DXCM Position: Q3 2022 in Review

MUFG Americas sold out of DexCom (DXCM) in Q3 2022, closing a stake of 100 shares — an estimated $7K sold.

MUFG Americas first reported a position in DXCM in Q2 2015 and held it in 9 quarters. The position peaked at $53K in Q4 2021. 795 funds tracked by Wall St. Rank hold DXCM as of Q3 2022.

  • MUFG Americas reported no remaining DexCom position as of Q3 2022 after selling out during the quarter.
  • MUFG Americas sold 100 DexCom shares in Q3 2022, an estimated $7K.
  • MUFG Americas first reported a position in DexCom in Q2 2015 and held it in 9 quarters.
  • MUFG Americas's DexCom position peaked at $53K in Q4 2021.
  • 795 funds tracked by Wall St. Rank held DexCom as of Q3 2022.

Based on MUFG Americas's 13F filing for Q3 2022, filed 1 Nov 2022.